Compounds > 3,3',4'-trihydroxyflavone
Page last updated: 2024-09-04

3,3',4'-trihydroxyflavone and 3',4'-dihydroxyflavone

3,3',4'-trihydroxyflavone has been researched along with 3',4'-dihydroxyflavone in 2 studies

Compound Research Comparison

Studies
(3,3',4'-trihydroxyflavone)		Trials
(3,3',4'-trihydroxyflavone)		Recent Studies (post-2010)
(3,3',4'-trihydroxyflavone)		Studies
(3',4'-dihydroxyflavone)		Trials
(3',4'-dihydroxyflavone)		Recent Studies (post-2010) (3',4'-dihydroxyflavone)
3902231014

Protein Interaction Comparison

ProteinTaxonomy3,3',4'-trihydroxyflavone (IC50)3',4'-dihydroxyflavone (IC50)
Poly [ADP-ribose] polymerase tankyrase-1Homo sapiens (human)0.2244
Poly [ADP-ribose] polymerase 1Homo sapiens (human)1.2795
Polyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)1.7
Dihydroorotate dehydrogenase Plasmodium falciparum (malaria parasite P. falciparum)9.48
Poly [ADP-ribose] polymerase tankyrase-2Homo sapiens (human)0.1739

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Hong, C; Jeong, S; Kim, KH; Lee, J; Park, T1
Fernandes, E; Fernandes, PA; Freitas, M; Oliveira, A; Proença, C; Ramos, MJ; Ribeiro, D; Silva, AMS; Sousa, JLC1

Other Studies

2 other study(ies) available for 3,3',4'-trihydroxyflavone and 3',4'-dihydroxyflavone

ArticleYear
3-Hydroxychromones as cyclin-dependent kinase inhibitors: synthesis and biological evaluation.
    Bioorganic & medicinal chemistry letters, 2007, Mar-01, Volume: 17, Issue:5

    Topics: Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Cell Survival; Chromones; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor Proteins; Humans; Inhibitory Concentration 50; Protein Binding; Structure-Activity Relationship

2007
Structural Specificity of Flavonoids in the Inhibition of Human Fructose 1,6-Bisphosphatase.
    Journal of natural products, 2020, 05-22, Volume: 83, Issue:5

    Topics: Drug Design; Enzyme Inhibitors; Flavonoids; Fructose; Fructose-Bisphosphatase; Humans; Hypoglycemic Agents; Liver; Molecular Structure

2020